Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 276Breast Neoplasms 266Lung Neoplasms 127Prostatic Neoplasms 124Colorectal Neoplasms 105Carcinoma, Non-Small-Cell Lung 104Pancreatic Neoplasms 70Carcinoma, Hepatocellular 58Stomach Neoplasms 55Hematologic Neoplasms 52Urinary Bladder Neoplasms 50Multiple Myeloma 50Ovarian Neoplasms 49Brain Neoplasms 49Esophageal Neoplasms 46Leukemia, Myeloid, Acute 45Melanoma 44Head and Neck Neoplasms 42Colonic Neoplasms 41Disease 40Neoplasm Metastasis 39Liver Neoplasms 39Rectal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma 32Uterine Cervical Neoplasms 31Endometrial Neoplasms 30Thyroid Neoplasms 29Recurrence 29Leukemia, Lymphocytic, Chronic, B-Cell 29

Interventions

Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Erectile Dysfunction × 90 days × Clear all
NCT07597798 2026-05-19

EVERiST

University College, London

Recruiting
40 enrolled

Erectile Dysfunction

NCT07460726 2026-03-10

PRIAPUS-PCa

CancerCare Manitoba

Not yet recruiting
130 enrolled
Genitourinary

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡